Head and Neck Cancer Trial, Recruiting NCT03875716 Sponsor: Dana-Farber Cancer Institute Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT03875716
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a specific type of throat cancer (squamous cell carcinoma) affecting the tonsil, base of the tongue, or an unknown primary site, confirmed by a tissue or cell sample
  • Your cancer is linked to HPV (human papillomavirus), confirmed by specific lab tests
  • Your doctors believe surgery can remove the cancer completely with no cancer cells left at the edges
  • Your surgery will be performed at Brigham & Women's Hospital
  • You are 18 years of age or older
  • You are generally healthy and able to carry out normal daily activities with little or no limitation (confirm with trial site)
  • Your blood, liver, and kidney test results are within acceptable ranges (confirm with trial site for specific values)
  • You have smoked 20 pack-years or fewer in your lifetime (for example, 1 pack per day for 20 years, or 2 packs per day for 10 years)
  • Your cancer is at an early stage — classified as T0, T1, or T2, and N0 or N1 (confirm with trial site)
  • Your cancer has not spread to other parts of the body
  • You are able to understand and are willing to sign a consent form

Who may not be able to join:

  • You have had a head or neck cancer diagnosis within the last 5 years
  • You have previously had radiation treatment to the head or neck area
  • You have lymph nodes in your neck that feel fixed in place or clumped together
  • You have a serious uncontrolled illness, such as an active infection, unstable heart condition, or a mental health condition that might make it difficult to follow the study requirements
  • You are currently pregnant (a pregnancy test will be required before joining)
  • You are currently breastfeeding — breastfeeding would need to be stopped before enrolling in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 May 2019
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Disease-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov